1. Report Overview
1.1 Overview of Findings
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered By This Analytical Report
1.5 Who Is This Report For?
1.6 Structure of the Report
1.7 Research and Analysis Methods
1.8 Exchange Rates
1.9 Frequently Asked Questions
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to Zika Virus
2.1 The Zika Virus
2.1.1 Flavivirus Structure
2.1.2 Zika Virus Replication Mechanism
2.1.3 Modes of Transmission
2.2 Outline of Previous Zika Outbreaks
2.3 Symptoms of ZIVD
2.3.1 Microcephaly

3. Zika Outbreak 2015/2016
3.1 The Progression of Zika in the Americas
3.2 Areas at Risk from Zika Infection
3.2.1 Areas with Ae.aegypti Populations
3.2.2 Areas with Ae.albopictus Populations
3.3 Containment Measures
3.3.1 Efforts in Affected Countries
3.3.2 Efforts in Un-Affected Countries
3.4 Basic Reproductive Number
3.4.1 Related Virus Basic Reproduction Numbers

4. Diagnostic Tools for the Detection of Zika Virus
4.1 The Infectious Disease Diagnostics Market
4.2 Infectious Disease Diagnostics Market Forecast, 2016-2026
4.3 Diagnosis of Zika Infection
4.3.1 Laboratory Tests for the Diagnosis of Zika Virus Disease
4.3.2 Commercial and Point-of-Care Tests
4.3.2.1 Biocan Diagnostics

5. Zika Virus Vaccine: Pipeline Candidates
5.1 Global Vaccine Market, 2014
5.2 Global Vaccine Market Forecast, 2016-2026
5.3 Leading Manufacturers of Human Vaccines
5.3.1 GlaxoSmithKline (GSK)
5.3.2 Merck & Co (MSD)
5.3.3 Sanofi
5.3.4 Pfizer
5.4 No Zika Virus Vaccine Currently Available
5.5 Zika Virus Vaccine Pipeline
5.5.1 Bharat Biotech
5.5.2 Sanofi Pasteur
5.5.3 Inovio Pharmaceuticals
5.5.4 Other Companies

6. Economic and Socio-Economic Effects of the Zika Virus Outbreak
6.1 Overview of Impact on Affected Nations
6.2 Zika Virus and Pregnancy in Affected Countries
6.3 Tourism and Major Events
6.3.1 Comparison with Other Viral Epidemics – Ebola Outbreak 2014
6.4 Healthcare Services and Support
6.5 Predicted Impact of Further Spread

7. Glossary

List of Tables
Table 1.1 Currency Exchange Rates, 2015
Table 2.1 Modes of Infection of the Zika Virus and Their Confirmation Status
Table 2.2 Number of Live Births (000’s) For a Selection of Countries in the Affected Region, 2011
Table 3.1 Countries/Territories with Active Zika Transmission as of 11th February 2016
Table 4.1 The Infectious Disease Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2026
Table 5.1 The Global Vaccines Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025
Table 6.1 Countries at Risk of Infection and Number of Tourists (millions), 2013
Table 6.2 Number of Live Births in US States at High and Low Risk of Active Zika Transmission, and the Percentage of Live Births of Each (%)
Table 6.3 Number of Live Births in US States at High Risk of Active Zika Transmission, 2014

List of Figures
Figure 2.1 Representation of the Structure of a Flavivirus
Figure 2.2 Representation of the Genome of a Flavivirus
Figure 2.3 The Federated States of Micronesia, Location of 2007 Zika Virus Outbreak, with Yap Island Highlighted
Figure 2.4 Map of Pacific Islands, with Area of French Polynesia Highlighted
Figure 2.5 A Comparison of the Head Size of an Infant with Microcephaly and Without
Figure 2.6 Cases of Suspected Microcephaly in Brazil from 2011 to 2016
Figure 3.1 Location of Camaçari, Brazil, First Location to Report Zika Virus in the Americas
Figure 3.2 Population Density Map of Brazil, with Major Cities Labelled
Figure 3.3 Areas Showing Zika Virus Transmission, December 2015 and January 2016, excluding Pacific Islands
Figure 3.4 Likelihood of Occurrence of Ae.aegypti across the Americas
Figure 3.5 Likelihood of Occurrence of Ae.aegypti across Europe and Africa
Figure 3.6 Likelihood of Occurrence of Ae. aegypti across the Asia-Pacific
Figure 3.7 Likelihood of Occurrence of Ae.albopictus across the Americas
Figure 3.8 Likelihood of Occurrence of Ae.albopictus across Europe and Africa
Figure 3.9 Likelihood of Occurrence of Ae.albopictus across the Asia-Pacific
Figure 4.1 The Infectious Disease Testing Market Forecast: Revenue ($bn) and AGR (%), 2014-2026
Figure 4.2 Pan American Health Organization Zika Diagnosis Advice, 2015
Figure 5.1 The Global Vaccines Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
Figure 6.1 Percentage of Live US Births That Occurred in States with a High Risk and Low Risk of Active Zika Transmission, 2014